Showing results (141-150 of 154) with videos related to
Sort By:
Pageof 16
Genome Medicine|June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W Y Tsui, Michael L Cheng, Maha Shady, et al.Nature Medicine|July 22, 2008
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study, Kerby Shedden, Jeremy M G Taylor, et al.Cancer Discovery|June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS LymphomaChristian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.Nature Genetics|September 22, 2014
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glandsIlan Weinreb, Salvatore Piscuoglio, Luciano G Martelotto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient OutreachSeyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, et al.Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.Pageof 16